News Paxman AB

Equities

PAX

SE0009806284

Delayed Nasdaq Stockholm Other stock markets 06:48:25 2024-06-14 am EDT			5-day change	1st Jan Change
47.3 ^SEK	+1.28%		-1.87%	+28.53%

May. 23	Paxman AB Appoints Karen Giddings Clakely to the Board	CI
May. 23	Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Press release from PAXMAN AB’s 2024 Annual General Meeting	May. 23	AQ
Paxman AB Appoints Karen Giddings Clakely to the Board	May. 23	CI
PAXMAN publishes its interim report for Q1 2024	May. 23	AQ
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23	CI
Paxman publishes the company’s annual report for 2023	Apr. 26	AQ
The shareholders of PAXMAN AB (publ) (”the Company”) are hereby invited to attend the Annual General Meeting on Thursday 23 May 2024 at 12:00 CEST.	Apr. 19	AQ
See Redeye's interview with CEO Richard Paxman	Feb. 23	AQ
Record year for Paxman!	Feb. 23	AQ
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 14	CI
Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm	Nov. 29	AQ
See CEO Richard Paxman presents at Redeye Life Science Day 2023 – 23 November	Nov. 27	AQ
See Redeye's interview with CEO Richard Paxman	Nov. 17	AQ
PAXMAN publishes its interim report for Q3 2023	Nov. 17	AQ
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023	Nov. 10	AQ
PAXMAN Announces that US Centers for Medicare and Medicaid Services (CMS) continues to support scalp cooling but decreases rate for 2024	Nov. 07	AQ
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	23-10-03	AQ
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	23-10-03	CI
See Redeye's interview with CEO Richard Paxman	23-08-25	AQ
PAXMAN publishes its interim report for Q2 2023	23-08-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Paxman AB

Equities

PAX

SE0009806284

Summary

Filters